Evidence map›Paper›PMID 31520998›Full record

ArticleCancer genetics2019

Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis.

Katie M Strobel, Jacquelyn N Crane, Kathryn L Bradford, Yalda Naeini, William A May, Vivian Y Chang

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. A Puzzling Case of Pouch Pathology.ACG case reports journal · 2021
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Katie M StrobelDepartment of Pediatrics, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States.
Jacquelyn N CraneDepartment of Pediatrics, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States; Division of Pediatric Hematology and Oncology, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States.
Kathryn L BradfordDepartment of Pediatrics, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States; Division of Pediatric Hematology and Oncology, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States.
Yalda NaeiniDepartment of Pathology, University of California Los Angeles Hospital, Los Angeles, CA, United States.
William A MayDepartment of Pediatrics, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States; Division of Pediatric Hematology and Oncology, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States; Jonsson Comprehensive Cancer Center, University of California Los Angeles, United States; Children's Discovery and Innovation Institute, University of California Los Angeles Hospital, Los Angeles, CA, United States.
Vivian Y ChangDepartment of Pediatrics, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States; Division of Pediatric Hematology and Oncology, University of California Los Angeles Mattel Children's Hospital, Los Angeles, CA, United States; Jonsson Comprehensive Cancer Center, University of California Los Angeles, United States; Children's Discovery and Innovation Institute, University of California Los Angeles Hospital, Los Angeles, CA, United States. Electronic address: vchang@mednet.ucla.edu.
Mattel Children's Hospital · USUniversity of California, Los Angeles · US

Funding

UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Robert M Prins · 2017 to 2026
$25.2M
Training in Developmental HematologyT32HL086345 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KOHN, DONALD B · 2007 to 2022
$3.8M
Regulation of Stem Cell Aging and Cancer by the Vascular NicheK08HL138305 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHANG, VIVIAN Y-J · 2017 to 2021
$891k
NCI NIH HHS P50 CA211015NHLBI NIH HHS K08 HL138305NHLBI NIH HHS T32 HL086345
6 · The paper itself

Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominant condition that predisposes to multiple malignancies, most commonly colorectal carcinoma, but has rarely been associated with lymphoma. We discuss one patient found to have Burkitt-like Lymphoma (BLL) with 11q aberration in the setting of previously undiagnosed FAP. We review the literature of FAP and associated malignancies and the provisional WHO classification of Burkitt-like lymphoma with 11q aberration. Both FAP and Burkitt-like lymphoma with 11q aberration involve perturbation of the MYC network and this may provide insight into a connection between these two diagnoses. However, further study is needed to elucidate if there is an increased risk of BLL and other subtypes of lymphoma among patients with FAP in order to provide optimal counseling and surveillance for patients with FAP.

Indexed as

Adenomatous Polyposis ColiBurkitt LymphomaAbdomenAdolescentChromosome AberrationsHumansMale11q aberrationBurkitt-like lymphomaFamilial adenomatous polyposisMYC network

Identifiers

PMID31520998
PMCPMC8123106
OpenAlexW2972168761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.